Standard BioTools Competitors and Similar CompaniesClear all

Standard BioTools's competitors and similar companies include Cytek Biosciences, Aclara, MILabs and IONpath.

	Standard BioTools Standard BioTools (formerly known as Fluidigm) is a biotechnology company that develops microfluidic-based chips and instrumentation for biological research.	Cytek Biosciences Cytek Biosciences is a manufacturer and supplier of flow cytometry products and services.	Aclara Aclara Technologies is a supplier of smart infrastructure solutions to water, gas, and electric utilities.	MILabs MILabs is a company that develops molecular imaging solutions for biomedical research.	IONpath IONpath is a company engaged in the development of tissue imaging technologies.
Founding Date	Founding Date 1999	Founding Date 1992	Founding Date 1972	Founding Date 2006	Founding Date 2014
Type	Type Public	Type Public	Type Subsidiary	Type Private	Type Private
Tags	Tags Healthcare biotech medical devices medical imaging	Tags Healthcare biotech medical devices	Tags Technology application software data management infrastructure smart home	Tags Healthcare biotech medical devices medical imaging	Tags Healthcare biotech medical devices medical imaging
Locations	Locations South San Francisco, US HQ Sydney, AU Markham, CA Shanghai, CN Paris, FR Paris, FR München, DE see more	Locations Fremont, US HQ Shanghai, CN Tokyo, JP Amsterdam, NL Amsterdam, NL Bethesda, US	Locations St. Louis, US HQ Concón, CL Hyderabad, IN Tokyo, JP Makati, PH Zamudio, ES Cambridge, GB see more	Locations Houten, NL HQ	Locations Menlo Park, US HQ
Employees	Employees 5393% increase	Employees 390	Employees 933	Employees 542% increase	Employees 166% decrease
Valuation ($)	Valuation ($) 649.5 m	Valuation ($) 632.5 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $85.3m (FY, 2025)	Revenue (est.) $201.5m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $42.8m (FY, 2025)	Cost of goods $97m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $42.5m (FY, 2025)	Gross profit $104.5m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income ($74.9m) (FY, 2025)	Net income ($66.5m) (FY, 2025)	Net income N/A	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 285.7m	Total funding raised $ 144.3m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 18m